The group’s principal activity is to develop novel, patent-protected technologies to provide competitive advantages to companies in the medical device market. The group product is MYO-VAD(TM). The group marketed its product under the trade name MYO-VAD(TM). The group operates from the United States. The group’s revenue in the year 2006 was $1,044,861.
